Ramucirumab is directed against VEGFR-2, and 64Cu-NOTA-RamAb, a ramucirumab-based PET tracer, was able to visualize VEGFR-2 expression in mice tumor models [77]. The gene discussed is KDR; the disease is neoplasm.